Clinical trial
Interleukin-2 in Treating Children Who Have Undergone Bone Marrow…
NCT00009698 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00009698 |
|---|---|
| Title | Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia |
| Official title | IL-2 Infusion in AML Patients After Autologous Bone Marrow Transplant: A Pediatric Oncology Group Wide Phase I Trial |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological |
| Interventions | aldesleukin |
| Enrollment | 1 |
| Start date | Mar 1, 1998 |
| Primary completion | Jun 1, 2001 |
| Completion | Sep 1, 2005 |
| First posted | Dec 31, 2003 |
| Last update posted | Jun 28, 2013 |
| Countries | Australia, Canada, Netherlands, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: